🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05694065
Active, not recruiting Observational

Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)

NCT05694065 · tracked via the Priya Life Science China tracker
Sponsor
Ruijin Hospital
Phase
Observational
Started
2023-02-17
Last updated
2026-07-24

Condition(s) studied

Ischemic Heart Disease

Study summary

Investigating the diagnostic accuracy of online Ultrasonic Flow Ratio (UFR) assessment to identify hemodynamically significant coronary stenosis in patients with suspected ischemic heart disease using angiography-derived fractional flow reserve (FFR) as a reference standard.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Subject must be ≥ 18 years * Patients suspected with ischemic heart disease * ≥ 1 diseased vessel with angiographic percent diameter stenosis between 40% and 80% in a vessel ≥ 2.5mm by visual estimation * Target vessels are limited to major epicardial coronary arteries (left anterior descending artery \[LAD\], left circumflex artery \[LCX\], right coronary artery \[RCA\]) Exclusion Criteria: * Patients with previous coronary artery bypass grafting (CABG) * Myocardial infarction within 72h of coronary angiography * Allergy to the contrast agent or adenosine * Left main coronary artery stenosis ≥ 50% * Target vessel with in-stent restenosis * Target vessel with severe tortuosity or angulation * 100% occlusion of target vessel * Target vessel spasm or injury * Target vessel with severe myocardial bridge * Target vessel with severe thrombosis * Intravascular ultrasound (IVUS) pullback fails to cover the complete target lesion * Presence of false lumen at target vessel based on IVUS * A serum creatinine level \>150 umol/l, or a glomerular filtration rate \< 45 ml/kg/1.73 m\^2 * Heart failure * Ineligible for diagnostic intervention (IVUS or FFR examination)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai Shanghai Municipality

More Ruijin Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05694065 on ClinicalTrials.gov ↗ ← All trials in China